115 related articles for article (PubMed ID: 12938223)
1. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.
Yachimovich-Cohen N; Fischel R; Bachar N; Yarkoni Y; Eilat D
Eur J Immunol; 2003 Sep; 33(9):2469-78. PubMed ID: 12938223
[TBL] [Abstract][Full Text] [Related]
2. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
[TBL] [Abstract][Full Text] [Related]
3. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
4. Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice.
Yarkoni Y; Fischel R; Kat I; Yachimovich-Cohen N; Eilat D
Eur J Immunol; 2006 Oct; 36(10):2755-67. PubMed ID: 16983722
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
Makdasi E; Fischel R; Kat I; Eilat D
J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
[TBL] [Abstract][Full Text] [Related]
6. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
Pewzner-Jung Y; Simon T; Eilat D
J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
[TBL] [Abstract][Full Text] [Related]
7. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
Kat I; Makdasi E; Fischel R; Eilat D
Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
[TBL] [Abstract][Full Text] [Related]
8. Stochastic pairing of Ig heavy and light chains frequently generates B cell antigen receptors that are subject to editing in vivo.
Novobrantseva T; Xu S; Tan JE; Maruyama M; Schwers S; Pelanda R; Lam KP
Int Immunol; 2005 Apr; 17(4):343-50. PubMed ID: 15710909
[TBL] [Abstract][Full Text] [Related]
9. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
10. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
[TBL] [Abstract][Full Text] [Related]
11. Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes.
Braun U; Rajewsky K; Pelanda R
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7429-34. PubMed ID: 10829061
[TBL] [Abstract][Full Text] [Related]
12. Expression of an anti-DNA-associated VH gene in immunized and autoimmune mice.
Ash-Lerner A; Ginsberg-Strauss M; Pewzner-Jung Y; Desai DD; Marion TN; Eilat D
J Immunol; 1997 Aug; 159(3):1508-19. PubMed ID: 9233650
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.
Fish F; Ziff M
J Immunol; 1982 Jan; 128(1):409-14. PubMed ID: 6976378
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
[TBL] [Abstract][Full Text] [Related]
15. Does the deletion within T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB X NZW)F1 mice?
Yanagi Y; Hirose S; Nagasawa R; Shirai T; Mak TW; Tada T
Eur J Immunol; 1986 Sep; 16(9):1179-82. PubMed ID: 3758154
[TBL] [Abstract][Full Text] [Related]
16. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
[TBL] [Abstract][Full Text] [Related]
17. Deletion and editing of B cells that express antibodies to DNA.
Chen C; Radic MZ; Erikson J; Camper SA; Litwin S; Hardy RR; Weigert M
J Immunol; 1994 Feb; 152(4):1970-82. PubMed ID: 8120401
[TBL] [Abstract][Full Text] [Related]
18. The site and stage of anti-DNA B-cell deletion.
Chen C; Nagy Z; Radic MZ; Hardy RR; Huszar D; Camper SA; Weigert M
Nature; 1995 Jan; 373(6511):252-5. PubMed ID: 7816141
[TBL] [Abstract][Full Text] [Related]
19. The immature B-cell subpopulation with low RAG1 expression is increased in the autoimmune New Zealand Black mouse.
Toda T; Kitabatake M; Igarashi H; Sakaguchi N
Eur J Immunol; 2009 Feb; 39(2):600-11. PubMed ID: 19180472
[TBL] [Abstract][Full Text] [Related]
20. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice.
Wang H; Shlomchik MJ
J Immunol; 1997 Aug; 159(3):1125-34. PubMed ID: 9233605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
